Open access
Open access
Powered by Google Translator Translator

Interventional Cardiology

M-A | The optimal timing for non-culprit PCI in patients with multivessel coronary artery disease.

21 Oct, 2022 | 12:52h | UTC

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials – Frontiers in Cardiovascular Medicine

 

Cohort Study | 3-year outcomes of patients with spontaneous coronary artery dissection.

19 Oct, 2022 | 14:23h | UTC

Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Editorial: Spontaneous Coronary Artery Dissection: Lower Than Expected Recurrence Rate in a Large Prospective Canadian Cohort – Journal of the American College of Cardiology

Commentary: SCAD Heart Attacks: Outcomes Not as Bad as Previously Feared – Daytonews

 

Cohort Study | Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention.

13 Oct, 2022 | 13:42h | UTC

Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention – openheart

 

Commentary on Twitter

https://twitter.com/Open_HeartBMJ/status/1580211725151784962

 

Review | Therapeutic management of anomalous coronary arteries originating from the opposite sinus of Valsalva.

11 Oct, 2022 | 13:32h | UTC

Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing – Journal of the American Heart Association

 

Commentary from the author on Twitter

Under a Creative Commons Attribution‐NonCommercial License

 

RCT | Abbreviated antiplatelet therapy after coronary stenting in patients with myocardial infarction at high bleeding risk.

29 Sep, 2022 | 13:32h | UTC

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk – Journal of the American College of Cardiology

Original publication: #ESCCongress – RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.

 

ESVS Clinical practice guidelines on radiation safety.

28 Sep, 2022 | 13:46h | UTC

European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Radiation Safety – European Journal of Vascular and Endovascular Surgery

 

RCT | Routine pressure wire assessment vs. conventional angiography in patients with coronary artery disease.

27 Sep, 2022 | 13:19h | UTC

Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial – Circulation

Related:

RCT: In patients with multivessel coronary artery disease, a Fractional Flow Reserve (FFR) guided revascularization strategy did not reduce the risk of ischemic cardiovascular events or death at 1-year follow-up compared to a traditional strategy without FFR.

RCT: In patients with three-vessel coronary artery disease, an FFR–guided PCI strategy was NOT noninferior to coronary bypass surgery – The 1-year incidence of the composite primary end point (death, myocardial infarction, or stroke) was 7.3% in the FFR-guided PCI group and 5.2% in the CABG group.

#ACC21 – RCT: In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not improve outcomes compared to an angiography-guided strategy.

 

Cohort Study | Incidence and outcomes of coronary artery perforations.

27 Sep, 2022 | 13:09h | UTC

Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study – Journal of the American Heart Association

 

Secondary analysis of a RCT | Complete revascularization vs. culprit lesion–only PCI for angina-related quality of life in patients with STEMI.

22 Sep, 2022 | 13:17h | UTC

Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Original Study: #ESCCongress – Randomized Trial: Complete Revascularization Superior to Culprit-lesion-only PCI in Patients with ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Coronary Artery Disease

Related meta-analysis:

Meta-analysis: multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease

Meta-Analysis: Complete vs. Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction

Study: Nonculprit-lesion PCI Timing in Patients With ST-Segment Elevation Myocardial Infarction

Studies in patients with cardiogenic shock:

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine

One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine

 

RCT | Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography.

22 Sep, 2022 | 13:04h | UTC

Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary: Intervention Cuts Risk for AKI After Coronary Angiography – HealthDay

 

Commentary on Twitter

 

RCT | Routine ultrasonography guidance for femoral vascular access for cardiac procedures improved first-pass success but did not reduce complications.

22 Sep, 2022 | 13:01h | UTC

Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial – JAMA Cardiology (free for a limited period)

Commentary: Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute? – JAMA Cardiology

 

Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.

20 Sep, 2022 | 13:34h | UTC

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial – Circulation

Commentary: 10-Year Data From BEST Trial Find No Significant Safety or MACE Differences Between PCI With EES Versus CABG – Cardiac Interventions Today

Original Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine

 

RCT | Cerebral embolic protection during transcatheter aortic-valve replacement did not significantly reduce the incidence of periprocedural stroke.

19 Sep, 2022 | 12:49h | UTC

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope – TCTMD

Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement – PROTECTED TAVR – American College of Cardiology

Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven — Large trial comes up short in proving a definitive benefit to debris filters – MedPage Today (free registration required)

News Release: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement – Cedars-Sinai

 

Commentary on Twitter

 

Review / Perspective | Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?

13 Sep, 2022 | 13:18h | UTC

Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? – European Heart Journal

 

Commentary on Twitter

https://twitter.com/ESC_Journals/status/1526080012729864198

 

Cohort Study | Incidence, timing, and causes of late bleeding after TAVR.

13 Sep, 2022 | 13:10h | UTC

Incidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort – JACC: Asia

Editorial: Late Bleeding Following TAVR in Japan: An Important Cause of Mortality – JACC: Asia

Commentary: Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI – TCTMD

 

RCT | Effects of Nicorandil administration on infarct size in patients with ST‐Segment–Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention.

11 Sep, 2022 | 22:37h | UTC

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial – Journal of the American Heart Association

 

RCT | Fractional flow reserve or intravascular ultrasonography to guide percutaneous coronary intervention.

2 Sep, 2022 | 13:15h | UTC

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Fractional Flow Reserve Noninferior to IVUS for Guiding PCI – HealthDay

 

#ESCCongress – M-A | Radial access for coronary interventions confers lower mortality than femoral access.

30 Aug, 2022 | 12:17h | UTC

News Release: Radial access for coronary interventions confers lower mortality than femoral access – European Society of Cardiology

Original Study: Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials – Circulation (free for a limited period)

Commentary: Less Death, Major Bleeding With Transradial Access: Meta-analysis – TCTMD

 

Commentary on Twitter

 

#ESCCongress – RCT | In patients with severe ischemic left ventricular systolic dysfunction under optimal medical therapy, revascularization by PCI did not improve outcomes.

29 Aug, 2022 | 12:38h | UTC

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Coronary stenting does not benefit patients with severe left ventricular dysfunction – European Society of Cardiology

Commentary: DANCAVAS: CV Screening Did Not Significantly Reduce Incidence of Death in Older Males – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – RCT | Routine functional testing is not better than standard care in high-risk patients after percutaneous coronary intervention.

29 Aug, 2022 | 12:32h | UTC

Routine Functional Testing or Standard Care in High-Risk Patients after PCI – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Bicuspid aortic valve stenosis: from pathophysiological mechanism, imaging diagnosis, to clinical treatment methods.

10 Aug, 2022 | 12:22h | UTC

Bicuspid Aortic Valve Stenosis: From Pathophysiological Mechanism, Imaging Diagnosis, to Clinical Treatment Methods – Frontiers in Cardiovascular Medicine

 

Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement.

4 Aug, 2022 | 14:35h | UTC

Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review – Journal of the American College of Cardiology

 

Commentary on Twitter

Under a http://creativecommons.org/licenses/by/4.0/ license

 

Cohort Study | Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-year clinical outcomes.

3 Aug, 2022 | 13:58h | UTC

Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Early LV Recovery After TAVI Points to Better 5-Year Survival – TCTMD

 

Commentary on Twitter

 

Review | Advances in percutaneous patent foramen ovale closure: from the procedure to the echocardiographic guidance.

1 Aug, 2022 | 12:14h | UTC

Advances in Percutaneous Patent Foramen Ovale Closure: From the Procedure to the Echocardiographic Guidance – Journal of Clinical Medicine

 

Cohort Study | Impact of peridevice leak on 5-year outcomes after left atrial appendage closure.

29 Jul, 2022 | 12:26h | UTC

Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Editorial: Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis – Journal of the American College of Cardiology

Commentary: Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes – TCTMD

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.